136 related articles for article (PubMed ID: 1920812)
21. [Clinical evaluation of imipenem/cilastatin sodium as a second line regimen in severe infections associated with hematologic disorders].
Tsuda S; Nakai H; Murakami T; Seryu S; Takashima T; Tanaka S; Nakagawa H; Nishigaki H; Okuda T; Nishida K
Jpn J Antibiot; 1991 Aug; 44(8):886-98. PubMed ID: 1920814
[TBL] [Abstract][Full Text] [Related]
22. Overall clinical utility of the intramuscular preparation of imipenem/cilastatin.
MacGregor RR
Chemotherapy; 1991; 37 Suppl 2():53-7. PubMed ID: 1879188
[TBL] [Abstract][Full Text] [Related]
23. Clinical efficacy of intravenous doripenem in patients with acute biliary tract infection: a multicenter, randomized, controlled trial with imipenem/cilastatin as comparator.
Tazuma S; Igarashi Y; Inui K; Ohara H; Tsuyuguchi T; Ryozawa S;
J Gastroenterol; 2015 Feb; 50(2):221-9. PubMed ID: 24795092
[TBL] [Abstract][Full Text] [Related]
24. Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulation.
Lee LS; Kinzig-Schippers M; Nafziger AN; Ma L; Sörgel F; Jones RN; Drusano GL; Bertino JS
Diagn Microbiol Infect Dis; 2010 Nov; 68(3):251-8. PubMed ID: 20851549
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of meropenem compared to imipenem-cilastatin in young, healthy males.
Nilsson-Ehle I; Hutchison M; Haworth SJ; Norrby SR
Eur J Clin Microbiol Infect Dis; 1991 Feb; 10(2):85-8. PubMed ID: 1864280
[TBL] [Abstract][Full Text] [Related]
26. [Clinical pharmacokinetics of an imipenem-cilastatin combination].
Singlas E
Presse Med; 1990 Apr; 19(13):598-605. PubMed ID: 2139939
[TBL] [Abstract][Full Text] [Related]
27. Intramuscular imipenem/cilastatin in multiple-dose treatment regimens: review of the worldwide clinical experience.
Garau J; Calandra GB
Chemotherapy; 1991; 37 Suppl 2():44-52. PubMed ID: 1879187
[TBL] [Abstract][Full Text] [Related]
28. [Clinical evaluation of intramuscular imipenem/cilastatin sodium in surgical infections].
Konaga E; Takeuchi H; Orita K; Fuchimoto S; Ogawa K; Kitagawa T; Tokuda N; Kimura H; Hamada F; Nishiyama Y
Jpn J Antibiot; 1991 Dec; 44(12):1341-50. PubMed ID: 1798068
[TBL] [Abstract][Full Text] [Related]
29. [Clinical studies on imipenem/cilastatin sodium in the perinatal period].
Matsuda S; Suzuki M; Oh K
Jpn J Antibiot; 1988 Nov; 41(11):1774-7. PubMed ID: 3210307
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of parenteral imipenem/cilastatin in patients on continuous ambulatory peritoneal dialysis.
Chan CY; Lai KN; Lam AW; Li PK; Chung WW; French GL
J Antimicrob Chemother; 1991 Feb; 27(2):225-32. PubMed ID: 2055813
[TBL] [Abstract][Full Text] [Related]
31. Intramuscular imipenem/cilastatin treatment of upper reproductive tract infection in women: efficacy and use characteristics.
McGregor JA; Christensen FB; French JI
Chemotherapy; 1991; 37 Suppl 2():31-6. PubMed ID: 1879185
[TBL] [Abstract][Full Text] [Related]
32. [Clinical evaluation of imipenem/cilastatin sodium against severe infections in patients with hematopoietic disorders].
Tsukada T; Katayama N; Kageyama S; Nishikawa M; Kobayashi T; Deguchi K; Shirakawa S; Minami N
Jpn J Antibiot; 1990 Dec; 43(12):2087-93. PubMed ID: 2086823
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics of intravenous imipenem/cilastatin during intermittent haemofiltration.
Alarabi AA; Cars O; Danielson BG; Salmonson T; Wikström B
J Antimicrob Chemother; 1990 Jul; 26(1):91-8. PubMed ID: 2211452
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic profiles of intravenous imipenem/cilastatin during slow hemodialysis in critically ill patients.
Kihara M; Ikeda Y; Shibata K; Masumori S; Ebira H; Shiratori K; Ueda S; Takagi N; Umemura S; Shionoiri H
Clin Nephrol; 1994 Sep; 42(3):193-7. PubMed ID: 7994939
[TBL] [Abstract][Full Text] [Related]
35. Steady-state pharmacokinetics of intramuscular imipenem-cilastatin in elderly patients with various degrees of renal function.
Pietroski NA; Graziani AL; Lawson LA; Bland JA; Rogers JD; MacGregor RR
Antimicrob Agents Chemother; 1991 May; 35(5):972-5. PubMed ID: 1854179
[TBL] [Abstract][Full Text] [Related]
36. Imipenem/cilastatin as secondary therapy for bacterial infections.
Kono K; Onuki K; Tohara S; Takeda S
Clin Ther; 1991; 13(4):448-56. PubMed ID: 1933995
[TBL] [Abstract][Full Text] [Related]
37. [Efficacy and safety of intramuscular imipenem/cilastatin (IPM/CS) for complicated urinary tract infections].
Shindo K; Hori T; Hayashi M; Kiyokawa S; Maeda K; Iwasaki S; Maruta N; Yamada J; Morimitsu H; Taide M; Hoshino K; Shimomae H; Matsuo R; Suzu H; Nishimura N; Hashiguchi J; Saito Y
Jpn J Antibiot; 1997 Jul; 50(7):628-39. PubMed ID: 9743908
[TBL] [Abstract][Full Text] [Related]
38. Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial.
Sakka SG; Glauner AK; Bulitta JB; Kinzig-Schippers M; Pfister W; Drusano GL; Sörgel F
Antimicrob Agents Chemother; 2007 Sep; 51(9):3304-10. PubMed ID: 17620371
[TBL] [Abstract][Full Text] [Related]
39. [Study of imipenem/cilastatin sodium in the perinatal period].
Ishikawa M; Soma A; Takada H; Mizukami A; Kitamura S; Shimizu T
Jpn J Antibiot; 1988 Nov; 41(11):1742-50. PubMed ID: 3210305
[TBL] [Abstract][Full Text] [Related]
40. [Laboratory and clinical studies on imipenem/cilastatin sodium plus amikacin sulfate in patients with severe infections complicating hematological disorders].
Hotta T; Morishima Y; Saito H; Kodera Y; Hirabayashi N; Tanaka M; Mizuno H; Suzuki H; Kato Y; Morishita Y
Jpn J Antibiot; 1991 May; 44(5):515-28. PubMed ID: 1880931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
